We are live on
!
Find out more
EAM
Empery Asset Management Portfolio holdings
AUM
$86.5M
This Fund
S&P 500
This Quarter
Est. Return
-34.27%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.5M
AUM Growth
-$2.81M
(-13%)
Cap. Flow
+$6.2M
Cap. Flow
% of AUM
33.6%
Top 10 Holdings %
Top 10 Hldgs %
79.94%
Holding
88
New
11
Increased
–
Reduced
13
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MMAT
Meta Materials Inc. Common Stock
MMAT
|
+$6.52M |
| 2 |
SELLAS Life Sciences
SLS
|
+$2.72M |
| 3 |
ETNB
89bio
ETNB
|
+$1.21M |
| 4 |
APLT
Applied Therapeutics
APLT
|
+$1.11M |
| 5 |
SKYAW
SkyAI Inc
SKYAW
|
+$343K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCC.WS
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
|
+$1.2M |
| 2 |
SBFM
Sunshine Biopharma
SBFM
|
+$1.1M |
| 3 |
VLNS
The Valens Company, Inc. Common Shares
VLNS
|
+$688K |
| 4 |
AIOS
AIOS Tech
AIOS
|
+$658K |
| 5 |
STLN
Starling Oncology
STLN
|
+$504K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.77% |
| 2 | Healthcare | 25.83% |
| 3 | Technology | 25.02% |
| 4 | Consumer Staples | 0.38% |
| 5 | Energy | 0% |
Similar funds
BCM
TI
LCM
AA
YAG
CL
TWM
BI
Empery Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Empery Asset Management held 88 positions worth $18.5M, down 13% from $21.3M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Empery Asset Management deployed $6.2M of net new capital in Q2 2022, opening 11 new positions. Its largest new stake was Meta Materials Inc. Common Stock: 43,706 shares worth $4.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 75% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Sunshine Biopharma Inc Warrant, an estimated $389K trimmed.
- Empery Asset Management's largest Q2 2022 buy was Meta Materials Inc. Common Stock: 43,706 shares worth $4.5M.
- Empery Asset Management's biggest Q2 2022 reduction was Sunshine Biopharma Inc Warrant, cutting an estimated $389K.
- Empery Asset Management fully exited BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a in Q2 2022, selling an estimated $1.2M.
- Empery Asset Management's ten largest holdings make up 80% of its $18.5M portfolio in Q2 2022.
- Empery Asset Management opened 11 new positions and closed 13 in Q2 2022.
- Empery Asset Management's portfolio value fell 13% quarter-over-quarter to $18.5M.
Based on Empery Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.